Clinical Trial Update: Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial [Phase 2]

View source ↗

Summary

A prospective, single-arm Phase II trial evaluating neoadjuvant immunochemotherapy for locally advanced cervical cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Neoadjuvant immunochemotherapy regimen (unspecified)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Cervical Cancers | Phase 2 | Status: RECRUITING